Glycerol 3-phosphate |
| Catalog No.GC36159 |
Le glycérol 3-phosphate est produit par la voie cytosolique de la glycérol 3-phosphate déshydrogénase par la réduction du phosphate de dihydroxyacétone À l'aide de NADH formé pendant la glycolyse.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 17989-41-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Glycerol 3-phosphate is produced by the cytosolic glycerol 3-phosphate dehydrogenase pathway. Cytosolic glycerol 3-phosphate dehydrogenase (GPDH) consumes NADH to produce glycolol 3-phosphate from dihydroxyacetone phosphate (DHAP). The generated glycolol 3-phosphate can cross the permeable outer mitochondrial membrane[1]. Glycerol 3-phosphate is unstable in its free form, and its stable salt form sn-Glycerol 3-phosphate lithium (GC61482) with the same biological activity is recommended.
Glycerol 3-phosphate alone can inhibit the proliferation of DU145 and A549 cells in a concentration-dependent manner, and Glycerol 3-phosphate can increase the sensitivity of cells to metformin. When the concentration of Glycerol 3-phosphate is equal to or less than 1mmol/L, it has no adverse effect on the oxygen consumption rate (OCR) of DU145 and A549 cells, but as the concentration of Glycerol 3-phosphate increases (10, 100mmol/L), OCR begins to be inhibited[2].
In C57Bl/6J mice, plasma intact fibroblast growth factor 23 (iFGF23) and C-terminal FGF23 (cFGF23) levels showed a dose-dependent increase after a single intraperitoneal injection of Glycerol 3-phosphate (50, 150 and 300mg/kg). Glycerol 3-phosphate increased the urine phosphate/creatinine ratio and decreased plasma 1,25-dihydroxyvitamin D3 levels[3]. In a myocardial ischemia-reperfusion (I/R) mouse model, glycerol 3-phosphate reduced myocardial infarction area (42 ± 2%) compared with the control group (56 ± 4%) by activating the quinone pool (Q-pool) to stimulate the production of ROS in complex III (antimycin A)[4].
References:
[1] Shen W, Wei Y, Dauk M, et al. Involvement of a glycerol-3-phosphate dehydrogenase in modulating the NADH/NAD+ ratio provides evidence of a mitochondrial glycerol-3-phosphate shuttle in Arabidopsis[J]. The Plant Cell, 2006, 18(2): 422-441.
[2] Xie J, Ye J, Cai Z, et al. GPD1 enhances the anticancer effects of metformin by synergistically increasing total cellular glycerol-3-phosphate[J]. Cancer research, 2020, 80(11): 2150-2162.
[3] Simic P, Kim W, Zhou W, et al. Glycerol-3-phosphate is an FGF23 regulator derived from the injured kidney[J]. The Journal of clinical investigation, 2020, 130(3): 1513-1526.
[4] Madungwe N B, Zilberstein N F, Feng Y, et al. Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart[J]. American journal of cardiovascular disease, 2016, 6(3): 93.
Average Rating: 5 (Based on Reviews and 10 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *